KUMAR FAMILY PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: P92024 | WIGAN, WN3 5HL
Showing results 351-400 of 468
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Fludrocortisone acetate | 20 | 1,128 | £160 | -81.0% ▼ |
| Dorzolamide and timolol | 20 | 135 | £218 | -86.0% ▼ |
| Terbinafine hydrochloride | 20 | 345 | £62 | -46.1% ▼ |
| 20 | 1,404 | £129 | -76.5% ▼ | |
| 20 | 20 | £2.2K | -44.0% ▼ | |
| 20 | 720 | £1.8K | +31.3% ▲ | |
| Salbutamol | 19 | 1,296 | £495 | +183.0% ▲ |
| Pizotifen malate | 19 | 700 | £29 | -76.9% ▼ |
| Rivastigmine | 19 | 1,064 | £395 | -72.4% ▼ |
| Alogliptin | 19 | 700 | £632 | -92.5% ▼ |
| Timolol | 19 | 510 | £130 | -78.5% ▼ |
| Adapalene and benzoyl peroxide | 19 | 1,275 | £543 | -64.4% ▼ |
| 19 | 1,530 | £4.1K | +28.4% ▲ | |
| 19 | 1,260 | £4.0K | -22.0% ▼ | |
| Linaclotide | 18 | 504 | £643 | -1.5% vs avg |
| Zinc oxide | 18 | 507 | £59 | -13.0% ▼ |
| Ropinirole hydrochloride | 18 | 1,012 | £392 | -83.1% ▼ |
| Tibolone | 18 | 1,204 | £198 | -41.2% ▼ |
| Sodium fluoride | 18 | 969 | £97 | -45.7% ▼ |
| Sodium chloride | 18 | 716 | £408 | -39.5% ▼ |
| 18 | 330 | £39 | -58.2% ▼ | |
| 18 | 1,080 | £489 | -38.7% ▼ | |
| Sucralfate | 17 | 7,544 | £8.4K | +102.4% ▲ |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 17 | 588 | £79 | -51.1% ▼ |
| Clonidine hydrochloride | 17 | 2,240 | £220 | -68.1% ▼ |
| Fluorouracil (Sunscreen) | 17 | 720 | £563 | -53.3% ▼ |
| 17 | 279 | £1.4K | -34.4% ▼ | |
| 17 | 1,199 | £577 | -78.9% ▼ | |
| 17 | 460 | £1.4K | -8.9% ▼ | |
| Mebeverine hydrochloride compound preparations | 16 | 840 | £731 | +41.5% ▲ |
| Moxonidine | 16 | 1,015 | £153 | -71.3% ▼ |
| Colesevelam hydrochloride | 16 | 3,600 | £1.5K | -57.8% ▼ |
| Powder thickener - starch based (0913161) | 16 | 4,230 | £118 | +11.4% ▲ |
| Etodolac | 16 | 532 | £262 | -42.2% ▼ |
| Prednisolone acetate | 16 | 90 | £31 | -12.2% ▼ |
| Dimeticone (Barrier) | 16 | 8,000 | £76 | +8.8% ▲ |
| Ivermectin | 16 | 780 | £452 | -24.7% ▼ |
| 16 | 3,000 | £28 | -36.4% ▼ | |
| 16 | 115 | £289 | -33.8% ▼ | |
| 16 | 840 | £1.2K | +151.1% ▲ | |
| Oxycodone hydrochloride/naloxone hydrochloride | 15 | 1,680 | £1.3K | -13.5% ▼ |
| Acamprosate calcium | 15 | 1,104 | £127 | -56.9% ▼ |
| Medroxyprogesterone acetate | 15 | 630 | £54 | -60.8% ▼ |
| Alfacalcidol | 15 | 2,040 | £402 | -87.9% ▼ |
| Pimecrolimus | 15 | 510 | £316 | -11.4% ▼ |
| Diclofenac sodium | 15 | 800 | £582 | -37.4% ▼ |
| Other individually formulated bought in preparations | 15 | 1,500 | £109 | -54.1% ▼ |
| 15 | 116 | £76 | -85.3% ▼ | |
| 15 | 38 | £238 | -58.0% ▼ | |
| 15 | 1,208 | £605 | -22.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.